Tianyin Pharmaceutical Co., Inc. to Host First Quarter Fiscal 2010 Earnings Conference Call and Webcast on Friday, November 13th, 2009 at 10:30 a.m. ET

Tuesday, November 10, 2009 General News J E 4
CHENGDU, China, Nov. 9 TianyinPharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier ofmodernized traditional Chinese medicine ('TCM') based in Chengdu, China, todayannounced that management will hold a conference call to discuss its fiscal2010 first quarter results at 10:30 a.m. ET on Friday, November 13, 2009.Financial results will be released prior to the market open on that day. APowerPoint presentation which provides further details on the quarter and therecently announced Sichuan Jiangchuan Pharmaceutical Co. Ltd. joint venturewill accompany management's discussion and can be accessed via the webcastlink.

A replay will be available through November 21, 2009 and can be accessedby dialing (800) 406-7325 (U.S.), (303) 590-3030 (Int'l), Pin Code 4182573.

Webcast Access Information

Access Link:

You will need to have the Windows Media Player on your desktop. For a freedownload: .

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized traditional Chinesemedicine in China. It was established in 1994 and acquired by the currentmanagement team in August 2003. It has a comprehensive product portfolio of39 products, 22 of which are listed in the highly selective National MedicineCatalog of the National Medical Insurance program. Tianyin owns and operatesthree GMP manufacturing facilities and an R&D platform supported by leadingChinese academic institutions. The company has a pipeline of 17pharmaceutical products pending approval. Tianyin has an extensive nationwidedistribution network throughout China with a sales force of 720 salespeople.Tianyin is headquartered in Chengdu, Sichuan Province with three manufacturingfacilities and a total of 1,365 employees. For more information about Tianyin,please visit .

Safe Harbor Statement

The Statements which are not historical facts contained in this pressrelease are forward-looking statements that involve certain risks anduncertainties including but not limited to risks associated with theuncertainty of future financial results, additional financing requirements,development of new products, government approval processes, the impact ofcompetitive products or pricing, technological changes, the effect of economicconditions and other uncertainties detailed in the Company's filings with theSecurities and Exchange Commission.Call Access Information: (877) 941-2321 from within the United States (480) 629-9714 if calling internationally Conference ID is 4182573

SOURCE Tianyin Pharmaceutical, Co., Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
AMD LASERS Names Dr. James Jesse as Medical Direct...
Autism Support Network and Hagar International Par...